Results 101 to 110 of about 430,558 (143)

The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data. [PDF]

open access: yesJ Ovarian Res
Barlow M   +9 more
europepmc   +1 more source

Mathematical modeling of the evolution of resistance and aggressiveness of high-grade serous ovarian cancer from patient CA-125 time series. [PDF]

open access: yesPLoS Comput Biol
Jitmana K   +6 more
europepmc   +1 more source

CA 125 and TB

BMJ Case Reports, 2021
We present two unusual presentations of extrapulmonary tuberculosis (EPTB) and more specifically intra-abdominal tuberculosis (TB). These cases were initially suspicious for ovarian cancer, presenting with non-specific symptoms, ultrasound-confirmed ascites and elevated cancer antigen 125 tumour marker (CA 125).
Mirae Park   +3 more
openaire   +2 more sources

?????????????????????? ???????????????????????????????????? ???????????? CA 125 ?? ?????????????????? ?????????? ?????????????? ?????????? ?????????????? ?????????? ???????????????????????????????? ??????????????

2012
?????? ?????????????????????????? ???? 125 ?????? ???????????????????????????????? ?????????????? ?????????????? ?????????????? ?????????? ?????????????? (????) ???????????? ???????????????? ???????????????? ???????????????????????????????????? ???????????? ?????????? ?????????????? ?? ?????????????????? ?????????? ?????????????? ?????????? ????????????
J. A. M. van Balen   +7 more
openaire   +3 more sources

CA-125 levels in endometriosis

Fertility and Sterility, 1986
CA-125 is a cellular antigen detected in many patients with ovarian cancer, but it has also been detected in patients with endometriosis. Preoperative CA-125 levels were drawn from 113 patients before they underwent laparoscopy. Patients were categorized into diagnostic groups on the basis of pathologic findings. CA-125 levels in patients with evidence
P E, Patton   +3 more
openaire   +2 more sources

CA-125 in gynecological malignancies

European Journal of Cancer and Clinical Oncology, 1987
CA-125 is an antigenic determinant that can be demonstrated in the majority of epithelial ovarian carcinomas. It can be measured in the serum with a radioimmunoassay by means of a monoclonal antibody. The tumor marker has a low specificity but high sensitivity for ovarian cancer, especially for serous cystadenocarcinoma.
W, Meier   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy